Oct. 21 at 10:39 PM
$KAPA “The presentation at ESMO has increased the visibility of ENV-105 within the oncology community, which may attract interest in partnerships or strategic collaborations.”
https://prismmarketview.com/kairos-pharma-announces-promising-interim-results-for-env-105-in-advanced-prostate-cancer-trial/